{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:51:56Z","timestamp":1773661916262,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T00:00:00Z","timestamp":1163635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Since the year 2000 a melanoma\/skin cancer screening campaign has been organized annually in Greece in the context of the Euromelanoma Screening Day Campaign.<\/jats:p><jats:p><jats:bold>Objectives\u2002<\/jats:bold> We aimed to analyse the characteristics of the screened population, to recognize relevant risk factors and to identify the cases of histologically confirmed malignant melanoma (MM) in individuals with suspicious skin lesions.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> An analysis of the completed screening forms from the years 2000\u20132004 was performed with respect to relevant demographic, epidemiological and clinical data.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> A total of 9723 individuals were screened, most of whom where below the age of 50\u00a0years (71%), female (59%), and of skin phototype II and III (76%). Sunburn during childhood was reported in 47% of participants, while 5% of the screened population had a personal or family history of melanoma. On clinical examination, 14.4% had actinic keratoses, 31.2% had dysplastic nevi, while 6.4% carried a presumptive diagnosis of non\u2010melanoma skin cancer. In the 2003\u20132004 screening campaign, 19 out of the 171 clinically suspicious lesions were histologically proven to be MM, the majority of which (58%) were \u2018thin\u2019 melanomas (Breslow's thickness of \u2264\u00a01\u00a0mm) of the superficial spreading type.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Our study suggested that, a melanoma\/skin cancer screening programme in a Mediterranean country, supported by an intense publicity campaign, attracted many individuals at risk for skin cancer and detected mostly thin melanomas of the superficial spreading type.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2006.01865.x","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T11:55:13Z","timestamp":1163678113000},"page":"56-62","source":"Crossref","is-referenced-by-count":44,"title":["Melanoma\/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece"],"prefix":"10.1111","volume":"21","author":[{"given":"A","family":"Stratigos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kedicoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Stefanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Haidemenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AD","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,16]]},"reference":[{"key":"e_1_2_5_2_2","volume-title":"GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide","author":"Ferlay J","year":"2001"},{"key":"e_1_2_5_3_2","volume-title":"Cancer Incidence in Five Continents","author":"Parkin DM","year":"2003"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11360"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.12.021"},{"key":"e_1_2_5_6_2","volume-title":"EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union","author":"Ferlay J","year":"1999"},{"key":"e_1_2_5_7_2","unstructured":"United States Preventive Services Task Force.Screening for skin cancer.Am J Prev Medical Special SupplementApril 2001."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70017-7"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00034-7"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.48.4.236"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90274-1"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00127.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.003"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(98)00029-7"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70041-Y"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70403-2"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.11.1037-a"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.9.678"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.032"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12<2703::AID-CNCR8>3.0.CO;2-Q"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2001.2029"},{"key":"e_1_2_5_22_2","first-page":"3","volume-title":"Melanoma: Critical Debates.","author":"Berwick M","year":"2002"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.9"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900115)65:2<375::AID-CNCR2820650233>3.0.CO;2-Z"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70100-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80968-1"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00211432"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200010020-00011"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08712.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1996.tb01122.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2006.01865.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2006.01865.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T22:25:14Z","timestamp":1696976714000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2006.01865.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1111\/j.1468-3083.2006.01865.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01865.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,16]]}}}